Renustat is a first-in-class, orally administered medication that inhibits HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase). It enhances erythropoiesis (production of red blood cells) by stimulating endogenous erythropoietin production and improving iron regulation. It also helps to overcome the EPO-suppressive effects caused by inflammation, leading to improved hemoglobin synthesis and red blood cell production by downregulating hepcidin levels, a key regulator of iron metabolism.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Indications: Renustat is indicated for the treatment of symptomatic anemia associated with chronic kidney disease (CKD) in adult patients. It is used to improve hemoglobin levels in these patients, especially when anemia becomes symptomatic.
Take Roxadustat orally, with or without food.
Adjust the dose based on hemoglobin levels, following the recommended sequence. Doses should be adjusted to maintain hemoglobin levels between 10 to 12 g/dL. Avoid rapid increases (>2.0 g/dL) in hemoglobin within 4 weeks to minimize risks.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.